Cerebroside-beta-glucosidase encapsulation in liposomes for Gaucher's disease treatment revisited.
Korablyov
V
V
Department of Biochemistry, The Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Zimran
A
A
Barenholz
Y
Y
D000042:Absorption; D004337:Drug Carriers; D016503:Drug Delivery Systems; D004795:Enzyme Stability; D005240:Feasibility Studies; D005776:Gaucher Disease / Q000188:drug therapy*; D005962:Glucosylceramidase / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D008055:Lipids / Q000737:chemistry; D008081:Liposomes / Q000737:chemistry; D012709:Serum Albumin / Q000737:chemistry / Q000494:pharmacology
D004337:Drug Carriers; D008055:Lipids; D008081:Liposomes; D012709:Serum Albumin; D005962:Glucosylceramidase